5-Alpha Reductase Inhibitors: How Finasteride and Dutasteride Fight Hair Loss

5-alpha reductase inhibitors are among the most effective pharmaceutical treatments for androgenetic alopecia (pattern hair loss). By targeting the enzyme responsible for converting testosterone to DHT — the primary hormone behind hair follicle miniaturization — these medications can slow, stop, or even partially reverse hair loss in many patients. This guide explains how 5-alpha reductase inhibitors work, compares the two main options, and covers what you need to know before starting treatment.

Understanding the 5-Alpha Reductase Enzyme

5-alpha reductase is an enzyme found in multiple tissues throughout the body, including the scalp, prostate, liver, and skin. Its primary function is converting testosterone into dihydrotestosterone (DHT), a more potent androgen hormone. While DHT plays important roles during male development, in adults it is a key driver of androgenetic alopecia.

There are three isoforms (types) of the enzyme:

• Type I: Found primarily in sebaceous glands, liver, and skin
• Type II: Found primarily in the prostate, hair follicles, and genital skin — most relevant for hair loss
• Type III: Found in various tissues; its role in hair loss is less well-defined

In genetically susceptible individuals, DHT binds to androgen receptors in scalp hair follicles, triggering a process called miniaturization. Over time, affected follicles produce progressively thinner, shorter, and less pigmented hairs until they may stop producing visible hair altogether.

How 5-Alpha Reductase Inhibitors Work

5-alpha reductase inhibitors (5-ARIs) block the enzyme's activity, reducing the conversion of testosterone to DHT. By lowering DHT levels — particularly at the hair follicle — these medications can:

• Slow or halt the progression of hair loss
• Allow miniaturized follicles to recover and produce thicker hair
• In some patients, promote visible regrowth in areas of thinning

The degree of improvement varies by individual and depends on factors including how long hair loss has been progressing, the extent of miniaturization, and consistent medication use.

Finasteride: The First-Line 5-ARI for Hair Loss

Finasteride (brand name Propecia® for hair loss) is an FDA-approved treatment for male androgenetic alopecia at the 1 mg daily dose. It selectively inhibits type II 5-alpha reductase, reducing serum DHT levels by approximately 70%.

Effectiveness

Clinical trial data supporting finasteride's efficacy for hair loss is robust:

• In pivotal clinical trials, approximately 83% of men maintained or increased hair count after 2 years of treatment
• Approximately 66% of men showed increased hair count compared to baseline
• Hair loss resumed in men who discontinued treatment, with hair counts returning toward pre-treatment levels over 12 months
• The vertex (crown) area tends to respond best, with the frontal hairline showing more modest improvement

Dosing

For hair loss: 1 mg daily (oral tablet). This is the standard FDA-approved dose. Higher doses (5 mg, marketed as Proscar® for BPH) have not been shown to provide additional hair loss benefit and may increase side effect risk.

Side Effects

In clinical trials, side effects were reported at modestly higher rates than placebo:

• Decreased libido (~1.8% vs. 1.3% placebo)
• Erectile dysfunction (~1.3% vs. 0.7% placebo)
• Decreased ejaculate volume (~0.8% vs. 0.4% placebo)

Most side effects resolved with continued use or upon discontinuation. The discussion around persistent side effects (post-finasteride syndrome) remains active in the medical literature.

Dutasteride: The More Potent Alternative

Dutasteride (brand name Avodart®) inhibits both type I and type II 5-alpha reductase, reducing serum DHT by approximately 90%. While FDA-approved for benign prostatic hyperplasia (BPH), it is used off-label for hair loss in some clinical settings. It is FDA-approved for hair loss in some countries (such as South Korea and Japan) but not in the United States.

Effectiveness

Head-to-head studies comparing dutasteride and finasteride for hair loss have shown:

• Dutasteride (0.5 mg daily) demonstrated superior hair count improvements compared to finasteride (1 mg daily) in a randomized controlled trial published in the Journal of the American Academy of Dermatology
• The greater DHT suppression with dutasteride likely accounts for its additional efficacy
• However, the incremental benefit over finasteride must be weighed against its more potent hormonal effects

Key Differences from Finasteride

• Broader enzyme inhibition: Blocks both type I and type II 5-alpha reductase
• Greater DHT reduction: ~90% vs. ~70% with finasteride
• Much longer half-life: Approximately 5 weeks vs. 6–8 hours for finasteride
• Slower clearance: Because of its long half-life, side effects may take months to resolve after discontinuation
• Off-label for hair loss in the US: Not FDA-approved for this indication in the United States

Finasteride vs. Dutasteride: Which Should You Choose?

The choice between finasteride and dutasteride typically depends on several factors:

• First-line treatment: Finasteride is generally recommended as the first option due to its FDA approval for hair loss, extensive safety data, and shorter half-life
• Insufficient response: Dutasteride may be considered for patients who don't respond adequately to finasteride after 12+ months
• Risk tolerance: Dutasteride's greater hormonal impact and longer half-life mean that side effects, if they occur, may be more pronounced and slower to resolve
• Provider guidance: This decision should always be made in consultation with a licensed provider familiar with your medical history

Combination Therapy

5-alpha reductase inhibitors are often most effective when combined with other treatments:

• Minoxidil: Working through a completely different mechanism (increased blood flow to follicles), minoxidil and a 5-ARI together may provide additive benefits
• Low-level laser therapy (LLLT): Some evidence suggests photobiomodulation may complement pharmaceutical treatment
• Ketoconazole shampoo: May have mild anti-androgen effects at the scalp level
• Platelet-rich plasma (PRP): Some clinicians incorporate PRP injections as an adjunct therapy

Important Considerations Before Starting Treatment

• Patience is required: Visible results typically take 6–12 months, with maximum benefit at 1–2 years
• Treatment is ongoing: Benefits reverse upon discontinuation. Hair loss typically resumes within 6–12 months of stopping
• Contraindicated in women of childbearing potential: 5-ARIs can cause birth defects in male fetuses. Women who are or may become pregnant should not handle crushed or broken tablets
• PSA screening impact: 5-ARIs lower PSA levels by approximately 50%, which must be accounted for in prostate cancer screening
• Blood donation restrictions: Men taking dutasteride should not donate blood for 6 months after the last dose

The Bottom Line

5-alpha reductase inhibitors remain the gold standard for pharmacological treatment of androgenetic alopecia. Finasteride is the established first-line option with decades of safety data, while dutasteride offers a more potent alternative for those who need it. Both medications require long-term commitment and medical supervision for optimal results. Working with a licensed provider ensures proper evaluation, appropriate medication selection, and ongoing monitoring of your treatment response.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.